![]() |
|
|
Vol. 56, Issue 5, 962-965, November 1999
Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Bonn, Germany
| |
Summary |
|---|
|
|
|---|
The muscarinic M2 receptor contains an orthosteric and an
allosteric site. Binding of an allosteric agent may induce a shift
of the equilibrium dissociation constant KD
of a radioligand for the orthosteric site. According to the
cooperativity model, the KA of
alloster binding is expected to be shifted to an identical extent
depending on whether the orthosteric site is occupied by the orthoster
or not. Here, the novel radioalloster [3H]dimethyl-W84
(N,N'-bis[3-(1,3-dihydro-1,3-dioxo-4-methyl-2H-isoindol-2-yl)propyl]-N,N,N',N'-tetramethyl-1,6-hexanediaminium diiodide) was applied to directly measure the
KA shift induced for the prototype
allosteric modulator gallamine by binding of N-methylscopolamine (NMS) to the orthosteric site of
porcine heart M2 receptors (4 mM
Na2HPO4, 1 mM KH2PO4,
pH 7.4; 23°C; data are means ± S.E.). First, in the common way,
the concentration-dependent inhibition by gallamine of
[3H]NMS equilibrium binding was measured and analyzed
using the cooperativity model, which yielded for the affinity of
gallamine binding at free receptors a pKA=
8.35 ± 0.09 and a cooperativity factor
= 46 (n = 5). The dissociation constant for gallamine binding at NMS-occupied receptors was predicted as
p(
· KA) = 6.69. Labeling of the
allosteric site by [3H]dimethyl-W84 allowed the measure
of competitive displacement curves for gallamine. The
Ki for gallamine at free receptors amounted to pKi,
NMS = 8.27 ± 0.39 (n = 5), which is in line with the prediction of
the cooperativtiy model. In the presence of 1 µM NMS, to occupy the
orthosteric site, gallamine displaced [3H]dimethyl-W84
with pKi,+NMS = 6.60 ± 0.19 (n = 3). Thus, the NMS-induced
pKi shift amounted to 47, which matches the
predicted value of
= 46. These results validate the
cooperativity model.
| |
Introduction |
|---|
|
|
|---|
Allosteric
modulation of ligand binding in muscarinic acetylcholine receptors has
been intensively studied (cf. Lee and El-Fakahany, 1991
; Tu
ek
and Pro
ka, 1995
; Ellis, 1997
; Christopoulos et al., 1998
;
Holzgrabe and Mohr, 1998
for review). Other G protein-coupled receptors
found sensitive for allosteric modulation include adenosine A1 receptors (Bruns and Fergus, 1990
),
2 adrenoceptors (Nunnari et al., 1987
; Wilson
et al., 1992
; Leppik et al., 1998
), and dopamine D2 receptors (Hoare and Strange, 1996
).
Allosteric modulation of G protein-coupled receptors offers the
possibility to increase the action of orthosteric agonists (e.g., Bruns
and Fergus, 1990
; Dole
al and Tu
ek, 1998
) with an extent
of subtype selectivity not achieved before (Birdsall et al., 1997
,
1999
).
The muscarinic acetylcholine M2 receptor is very
sensitive to allosteric modulation (e.g., Lee and El-Fakahany, 1991
;
Christopoulos et al., 1998
; Holzgrabe and Mohr, 1998
for review) and
may be considered as a model system to study allosteric interactions at
G protein-coupled receptors.
Until very recently, the receptor binding characteristics of an
allosteric agent could not be measured directly but were deduced from
the effects induced by the allosteric compound on the binding of an
orthosteric radioligand. The effect on the equilibrium binding of the
radioorthoster was analyzed by means of the ternary complex model of
allosteric interactions, the so-called "cooperativity model", which
has been introduced into the muscarinic field by Stockton et al.
(1983)
, simplified by Ehlert (1988)
, and further developed by Lazareno
and Birdsall (1995)
to cover an array of different experimental
situations. The alloster-induced KD shift of the orthosteric ligand is indicated by the cooperativity factor
.
The cooperativity model predicts that
is reciprocal in nature, i.e.,
equals the shift in induced by the orthosteric ligand. However, to date, this prediction has not been tested by direct binding
measurements at the allosteric site. Recently, we found a radioligand
for labeling the allosteric site in muscarinic acetylcholine M2 receptors, i.e.,
[3H]dimethyl-W84
(N,N'-bis[3-(1,3-dihydro-1,3-dioxo-4-methyl-2H-isoindol-2-yl)propyl]-N,N,N',N'-tetramethyl-1,6-hexanediaminium diiodide) (Tränkle et al., 1998
). Applying this compound, we aimed to find out whether the orthoster-induced shift of alloster binding affinity occurs as predicted by the cooperativity model. Therefore, we studied the interaction of the orthosteric ligand N-methylscopolamine (NMS) with the prototype allosteric
modulator gallamine. We chose gallamine because it acts via the
"common site" (Ellis and Seidenberg, 1992
; Tränkle and Mohr,
1997
) and because gallamine is known to display an intermediate
negative cooperativity with NMS that should be large enough to be
measurable in [3H]dimethyl-W84 binding
experiments. First, we determined the effect of gallamine on the
binding of the orthosteric ligand [3H]NMS in
the "conventional" way and obtained the cooperativity factor
by
an analysis of the data according to the cooperativity model. Second,
applying the radioalloster [3H]dimethyl-W84, we
measured in competition experiments the Ki of gallamine binding at the allosteric site either in the absence or in
the presence of NMS (at a concentration saturating the orthosteric site). According to the cooperativity model, the orthoster-induced shift of the Ki of alloster binding should
match the cooperativity factor
.
| |
Materials and Methods |
|---|
|
|
|---|
Membrane Preparation.
Homogenates of porcine myocardium were
prepared as described previously in detail (Tränkle et al.,
1996
). In short, at an ambient temperature of 3-6°C, pieces of the
ventricular myocardium of freshly excised hearts of domestic pigs were
washed in sucrose solution (0.32 M) and homogenized using a Waring
Blender and a Potter-Elvejhem homogenizer. After centrifugation of the
homogenate for 11 min at 300g (2000 rpm in a Beckman rotor
35; Beckman-Coulter, Fullerton, CA), the resulting supernatants
were pelleted for 15 min at 20,900g (13,000 rpm in a Beckman
rotor 35). The final pellets were resuspended in a buffer composed of 4 mM Na2HPO4, 1 mM
KH2PO4, pH 7.4 (Na, K,
Pi-buffer). Aliquots of 1 ml in volume were
shock-frozen in liquid nitrogen and stored at
80°C. The protein
content ranged between 4.5 and 9 mg/ml membrane suspension.
Binding Assays.
Binding experiments were carried out
applying a centrifugation assay as described previously for measurement
of [3H]dimethyl-W84 binding (Tränkle et
al., 1998
). Homogenate at a protein concentration of from 300 to 700 µg/ml was incubated in a volume of 1.5 ml with
[3H]dimethyl-W84 or
[3H]NMS, respectively, in the Na, K,
Pi-buffer at a temperature of 23°C. The
incubation time was 2 h unless otherwise indicated. [3H]dimethyl-W84 experiments were carried out
either in the absence or in the presence of 1 µM NMS to occupy the
orthosteric binding site of the M2 receptor
and 1 µM physostigmine was applied to exclude an interaction of
[3H]dimethyl-W84 with acetylcholinesterase. At
the indicated concentrations, neither NMS nor physostigmine interacted
with the allosteric site of the
[3H]NMS-occupied M2
receptor (data not shown). Membranes were separated by centrifugation
with 20,900g (15,300 rpm) for 20 min at 23°C (Beckman
rotor model F241.5). After quickly rinsing the pellet with 1.5 ml of
cold Na, K, Pi-buffer to remove residual radioactivity from the tube
wall, the pellet was resuspended in 1.5 ml of buffer and transferred
into a scintillation vial filled with 10 ml of Ready Protein (Beckman)
for liquid scintillation counting.
Effects of Gallamine on [3H]Dimethyl-W84
Binding.
[3H]dimethyl-W84 was applied at a
concentration of 0.3 nM. In the experiments with 1 µM NMS, the
orthosteric ligand was allowed to equilibrate for 5 to 10 min with the
receptors before [3H]dimethyl-W84 was added to
the assay. As shown previously (Tränkle et al., 1998
),
[3H]dimethyl-W84 binding consists of three
fractions. Nonspecific, nonsaturable
[3H]dimethyl-W84 binding as determined in the
presence of high concentrations of unlabeled allosters amounts to about
20% of total [3H]dimethyl-W84 binding
(Tränkle et al., 1998
). In the following, it is focused on the
saturable binding, which is composed of a specific and a nonspecific
fraction. The binding constant of specific [3H]dimethyl-W84 binding (about 20-30% of the
total) as determined in homologous competition experiments, amounted in
the absence of NMS to (mean ± S.E.)
pKD = 8.89 ± 0.18 (four experiments), and in the presence of 1 µM NMS, to pKD = 8.74 ± 0.08 (seven experiments) respectively (Tränkle et
al., 1998
). The effect of gallamine on the binding of
[3H]dimethyl-W84 (0.3 nM) was determined under
identical conditions in heterologous competition experiments.
Effects of Gallamine on [3H]NMS Binding.
Binding of [3H]NMS (0.2 nM) under control
conditions was investigated by homologous competition experiments.
Nonspecific [3H]NMS binding was determined in
the presence of 1 µM atropine and did not exceed 10% of total
binding. The
log equilibrium dissociation constant
pKD amounted to 9.68 ± 0.10 (mean ± S.E.; eight experiments). The effect of gallamine on the
equilibrium binding of the orthosteric radioligand was determined in
inhibition experiments carried out simultaneously at 0.18 and 1.55 nM
[3H]NMS. The incubation time sufficient to
obtain equilibrium binding of [3H]NMS in the
presence of gallamine was deduced from the action of gallamine on
[3H]NMS dissociation according to an equation
adopted from Lazareno and Birdsall (1995)
:
|
Data Analysis.
Data from experiments not involving the
application of the ternary complex model of allosteric interactions
were analyzed individually by computer-aided, nonlinear regression
analysis using Prism ver. 3.0 (GraphPad, San Diego, CA). Analysis of
homologous and heterologous competition data obtained with the
respective radioligand was based on the general Hill equation. Because
the observed Hill coefficients did not differ significantly from unity (partial F test; P > .05; data not shown),
IC50 values were determined from curve fits with
nH fixed to 1. The binding parameter
KD was calculated according to DeBlasi et
al. (1989)
. Ki values for the inhibitory
action of gallamine on [3H]dimethyl-W84 binding
were obtained from IC50 values according to Cheng
and Prusoff (1973)
.
|
is the
cooperativity factor for the interaction between the allosteric
modulator and the radioligand.
Simultaneous nonlinear fitting of inhibition curves obtained at the low
and the high concentration of [3H]NMS with, as
two independent variables, the concentrations of gallamine and
[3H]NMS, respectively, was performed applying
Sigma Plot for Windows (version 4.00; SPSS, Erkrath, Germany).
Drugs.
Synthesis of dimethyl-W84 has been described
previously (Tränkle et al., 1998
). The synthesis of the
radiolabeled compound [3H]dimethyl-W84 was
carried out by Amersham Life Science (Braunschweig, Germany). The
radiochemical purity was 97%, and the specific activity amounted to
168 Ci/mmol = 6.22 Tbq/mmol. [3H]NMS was
purchased from DuPont/NEN (Bad Homburg, Germany), and atropine sulfate,
(
)scopolamine N-methylbromide, and gallamine triethiodide
were obtained from Sigma Chemicals (Munich, Germany).
| |
Results and Discussion |
|---|
|
|
|---|
Figure 1 depicts the effect of
increasing concentrations of the allosteric modulator gallamine on the
binding of the orthosteric ligand [3H]NMS at a
low (0.18 nM) and a high (1.55 nM) concentration. At both
[3H]NMS concentrations, gallamine reduced
radioligand binding concentration-dependently, indicating its negative
cooperativity with NMS. Whereas at the lower radioligand concentration,
the gallamine inhibition curve approached the zero level of
[3H]NMS binding, inhibition by gallamine at the
higher concentration of [3H]NMS was incomplete
and plateaued above the zero level, thus revealing the allosteric
character of the interaction. The ternary complex model of allosteric
interactions according to Ehlert (1988)
was applied for simultaneous
curve fitting to the two sets of data. The
log value of the
equilibrium dissociation constant for gallamine binding to free
receptors was computed to amount to pKA = 8.35 ± 0.09 (mean ± S.E.; five experiments), and the factor
of cooperativity between gallamine and [3H]NMS
was
= 46. This
value means that gallamine binding to the
receptor is accompanied by a 46-fold decrease in
[3H]NMS binding affinity compared with
[3H]NMS binding to free receptors. Because
cooperativity is reciprocal in nature, this finding predicts that the
affinity constant of gallamine at NMS occupied receptors is decreased
by the same factor: p(
· KA) = 6.69.
|
To check the predictions, we applied the radioalloster
[3H]dimethyl-W84 (0.3 nM) to measure the
Ki of gallamine at free and NMS-liganded
M2 receptors (Fig.
2). Because there is a negative cooperativity between gallamine and NMS (cf. Fig. 1), the question arises whether high concentrations of gallamine reduce occupation of
the orthosteric site by 1 µM NMS to a relevant extent. In the absence
of gallamine, 1 µM NMS (pKD = 9.68) leads
to a fractional receptor occupancy of 0.9998. From the characteristics
of the inhibition of [3H]NMS equilibrium
binding by gallamine (see Fig. 1), it can be derived by using the
cooperativity model that the fractional receptor occupancy by 1 µM
NMS in the presence of the highest applied concentration of gallamine
(1 mM) amounts to 0.9905. Accordingly, occupancy of the orthosteric
site by NMS is maintained even at high concentrations of gallamine. In
other words, the NMS receptor complex can be considered as an entity
that represents the binding site of
[3H]dimethyl-W84 and gallamine.
|
As reported recently (Tränkle et al., 1998
), inhibition of
[3H]dimethyl-W84 binding by increasing
concentrations of gallamine at NMS-occupied M2
receptors proceeds in a biphasic fashion (Fig. 2, inset), with the
high-affinity component representing specific binding to the allosteric
site. The rather high nonspecific binding is probably due to the use of
centrifugation for separating the membranes instead of filtration with
subsequent washes. However, the kinetics of
[3H]dimethyl-W84 binding at NMS-occupied
receptors are probably very fast (Tränkle and Mohr, 1997
) and,
therefore, the centrifugation procedure is currently the only feasible
experimental approach to measure radioalloster binding at NMS-occupied
M2 receptors under equilibrium conditions (Hulme,
1992
). In the absence of NMS, the biphasic shape of the curve for
inhibition of [3H]dimethyl-W84 binding by
gallamine was maintained. Under both conditions, with and without NMS,
there was a plateau between the two components of saturable
[3H]dimethyl-W84 binding at a gallamine
concentration of 3 µM. By defining nonspecific
[3H]dimethyl-W84 binding as the binding in the
presence of 3 µM gallamine, the results depicted in the main part of
Fig. 2 focus on the high-affinity specific component of
[3H]dimethyl-W84 binding. The curves
have the shape of competitive displacement curves. It is obvious from
Fig. 2 that 1 µM NMS occupying the orthosteric receptor site induced
a pronounced rightward shift of the gallamine inhibition curve. The
nonspecific low-affinity component of the gallamine displacement curve
was not shifted by NMS (Fig. 2, inset). The respective
IC50 concentrations inducing half-maximum
inhibition of specific [3H]dimethyl-W84 binding
by gallamine were converted to (
log) Ki values according to Cheng and Prusoff (1973)
and amounted to
pKi = 8.27 ± 0.39 (mean ± S.E.;
five experiments) at free M2 receptors and to
pKi = 6.60 ± 0.19 (mean ± S.E.;
three experiments), at NMS-occupied receptors. The latter value
corresponds favorably with the previously found
pKi = 6.72 (Tränkle et al., 1998
). The reduction of gallamine affinity by NMS corresponded to a shift in
the binding constant of gallamine by a factor of 47. The large scatter
bars may raise the question whether the shift is significant. Statistical testing revealed a significant difference between the
respective pKi values (unpaired
t test; P < .03). Also, the data are better
described by two distinct curves than by a single curve through the
joint data (F test; P < .001).
Figure 3 compiles in the form of a bar
graph the binding characteristics of gallamine at free and NMS-occupied
M2 receptors as derived from the experiments with
[3H]NMS and with
[3H]dimethyl-W84, respectively. The gallamine
binding constants for the interaction with free and with NMS-occupied
M2 receptors were independent of whether the
radioligand for the orthosteric site or the radioligand for the
allosteric site was used. Accordingly, the measured value of the
NMS-induced shift of gallamine binding affinity is identical with the
shift predicted by the cooperativity model.
|
In conclusion, the binding characteristics of allosteric agents in G protein-coupled receptors are commonly deduced from alloster effects on the binding of a radioligand for the orthosteric receptor site. Here, the feasibility of the underlying ternary complex model of allosteric interactions was demonstrated by using a new [3H]ligand for direct measurement of alloster binding at muscarinic M2 receptors.
| |
Acknowledgments |
|---|
The excellent technical assistance of Iris Witten and Frauke Mörschel is gratefully acknowledged.
| |
Footnotes |
|---|
Received May 17, 1999; Accepted July 29, 1999
This work was supported by the Deutsche Forschungsgemeinschaft.
Send reprint requests to: Klaus Mohr, Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany. E-mail: K.Mohr{at}uni-bonn.de
| |
Abbreviations |
|---|
M2 receptor, M2 subtype of muscarinic acetylcholine receptor; NMS, N-methylscopolamine; dimethyl-W84, N, N'-bis[3-(1,3-dihydro-1,3-dioxo-4-methyl-2H-isoindol-2-yl)propyl]-N, N,N',N'-tetramethyl-1,6-hexanediaminium diiodide; KA, equilibrium dissociation constant for alloster binding to free receptors.
| |
References |
|---|
|
|
|---|
al V and
Tu
ek S
(1998)
The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.
Br J Pharmacol
124:
1213-1218[Medline].
A Practical Approach (Hulme EC ed) p 235,
Oxford University Press, New York.
E,
Botero Cid HM,
Holzgrabe U and
Mohr K
(1998)
Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine receptors.
Mol Pharmacol
54:
139-145
ek S and
Pro
ka J
(1995)
Allosteric modulation of muscarinic acetylcholine receptors.
Trends Pharmacol Sci
16:
205-212[Medline].This article has been cited by other articles:
![]() |
D. S. Redka, L. F. Pisterzi, and J. W. Wells Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor Mol. Pharmacol., September 1, 2008; 74(3): 834 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7 Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Trankle, O. Weyand, U. Voigtlander, A. Mynett, S. Lazareno, N. J. M. Birdsall, and K. Mohr Interactions of Orthosteric and Allosteric Ligands with [3H]Dimethyl-W84 at the Common Allosteric Site of Muscarinic M2 Receptors Mol. Pharmacol., July 1, 2003; 64(1): 180 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. J. Hoare, S. K. Sullivan, N. Ling, P. D. Crowe, and D. E. Grigoriadis Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists Mol. Pharmacol., March 1, 2003; 63(3): 751 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Greney, D. Urosevic, S. Schann, L. Dupuy, V. Bruban, J.-D. Ehrhardt, P. Bousquet, and M. Dontenwill [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1 Imidazoline Receptors Mol. Pharmacol., July 1, 2002; 62(1): 181 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zahn, N. Eckstein, C. Trankle, W. Sadee, and K. Mohr Allosteric Modulation of Muscarinic Receptor Signaling: Alcuronium-Induced Conversion of Pilocarpine from an Agonist into an Antagonist J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buller, D. P. Zlotos, K. Mohr, and J. Ellis Allosteric Site on Muscarinic Acetylcholine Receptors: A Single Amino Acid in Transmembrane Region 7 Is Critical to the Subtype Selectivities of Caracurine V Derivatives and Alkane-Bisammonium Ligands Mol. Pharmacol., January 1, 2002; 61(1): 160 - 168. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||